secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2026-01-29T23:59:59+00:00
Accession:  0001213900-26-009157
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics enters $6M equity line of credit with Tumim Stone Capital
-------------------------------------------------------------------------------

- Company may sell up to $6M of common stock at 95-97% of VWAP discount.
- Commitment fee of $45,000 paid to investor upon execution.
- Shares subject to Exchange Cap (19.99% of outstanding) unless stockholder waiver obtained.
- Company must seek stockholder approval at next annual meeting to waive Exchange Cap.
- Investor cannot own more than 4.99% (or 9.99% at its election) of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/0001213900-26-009157-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026009157/ea0274173-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-009157

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer